Home › Follicular Lymphoma › Ohio › Columbus
Pag-aaral pangklinika para sa Follicular Lymphoma sa Columbus, OH
Isang pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Nagre-recruitPhase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Epco, Zanu, Ritux for R/R FL or MZL
Nagre-recruitPhase 2
- The Ohio State University Wexner Medical Center, Columbus
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
- The Ohio State University (OSU), Columbus
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Nagre-recruitPhase 3
- Research Site, Columbus
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Nagre-recruitPhase 2
- Research Site, Columbus
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Nagre-recruitObservasyonal na pag-aaral
- OhioHealth Research Institute, Columbus
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
Nagre-recruitPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
- The Ohio State University Wexner Medical Center, Columbus
Epcoritamab and Rituximab for First-line Follicular Lymphoma
Nagre-recruitPhase 2
- The Ohio State University Wexner Medical Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
Nagre-recruitPhase 1
- The Ohio State University - The James Cancer Hospital, Columbus
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Nagre-recruitPhase 1
- Ohio State University, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Columbus
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Nagre-recruitPhase 1
- The Ohio State University - The James Cancer Hospital and Solove Research Institute, Columbus
Pag-aaral para sa Follicular Lymphoma sa ibang lungsod
- New York City, NY24 pag-aaral
- Milwaukee, WI19 pag-aaral
- Nashville, TN18 pag-aaral
- Houston, TX18 pag-aaral
- Boston, MA17 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Seattle, WA15 pag-aaral
- Durham, NC15 pag-aaral
- Salt Lake City, UT13 pag-aaral
- Chicago, IL12 pag-aaral
- San Antonio, TX12 pag-aaral
- Philadelphia, PA12 pag-aaral
Iba pang pag-aaral sa Columbus
- Non-Small Cell Lung Cancer56 pag-aaral
- Kanser sa Suso39 pag-aaral
- Kanser sa Ovary39 pag-aaral
- Kanser (lahat ng uri)38 pag-aaral
- Kanser sa Baga37 pag-aaral
- Acute Myeloid Leukemia35 pag-aaral
- Chronic Lymphocytic Leukemia28 pag-aaral
- Metastatic Cancer27 pag-aaral
- Kanser ng Endometrium25 pag-aaral
- Colorectal Cancer24 pag-aaral
- Kanser sa Prostate24 pag-aaral
- Multiple Myeloma24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.